Royce & Associates LP Axogen, Inc. Transaction History

Royce & Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 09, 2019	SELL	$14.62 - $22.13 $1.48 Million - $2.24 Million	-101,000 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$17.09 - $38.25 $700,690 - $1.57 Million	41,000 Added 68.33%	101,000 $2.06 Million
Q2 2018 Aug 09, 2018	SELL	$36.15 - $52.5 $289,200 - $420,000	-8,000 Reduced 11.76%	60,000 $3.02 Million
Q1 2018 May 14, 2018	BUY	$24.4 - $40.25 $1.66 Million - $2.74 Million	68,000 New	68,000 $2.48 Million

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.